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ReviewCytokine Signaling in 2002:
New Surprises in the Jak/Stat Pathway
nated p35 and p40, the latter having homology to cyto-
kine receptors. Recently a new partner for p40 has been
identified, p19. This new cytokine is denoted IL-23 (Opp-
John J. O’Shea,1,3 Massimo Gadina,1
and Robert D. Schreiber2
1Molecular Immunology and Inflammation Branch
National Institutes of Arthritis mann et al., 2000), and it binds IL-12R1 but not IL-
12R2. The receptor WSX-1/TCCR has homology to IL-Musculoskeletal and Skin Diseases
National Institutes of Health 12R2, and its deficiency is associated with deficits in
cell-mediated immune responses and IFN- productionBethesda, Maryland 20852
2 Department of Pathology and Immunology (Chen et al., 2000b; Yoshida et al., 2001); this phenotype
makes it a possible candidate for an IL-23R subunit.Washington University School of Medicine
St. Louis, Missouri 63105 The IFN family or Type II family of cytokine receptors
includes the receptors for IFN-/, IFN-, IFN-, and IL-
10. New members of this family include limitin, IL-19,
IL-20, IL-22/ IL-TIF, IL-24 (mda-7), and IL-26 (AK155)The importance of Jak-Stat pathway signaling in reg-
ulating cytokine-dependent gene expression and cell- (Blumberg et al., 2001; Takahashi et al., 2001; Xie et al.,
2000). The precise physiologic functions of these newular development/survival is well established. Never-
theless, advances continue to be made in defining cytokines are uncertain, but this will surely be of interest.
Efforts are now being made to create artificial, nonpro-Jak-Stat pathway effects on different cellular pro-
cesses and in different organisms. This review focuses tein ligands that bind Type I cytokine receptors based on
the crystal structure of the ligand/receptor interactionson recent advances in the field and highlights some
of the most active areas of Jak-Stat pathway research. (Guo et al., 2000). Given the wide physiologic functions
of this family, it is exciting to consider the possibility that
small molecule agonists/antagonists will be generated.Introduction
Cytokines that bind the Type I family of cytokine recep-
tors play critical roles in the development and differenti- Janus Kinases
ation of diverse cells. Like the interferons (IFNs), which With completion of the draft sequence of the human
bind receptors designated as the Type II cytokine recep- genome, it appears that only four members of the mam-
tor family, Type I cytokines also have essential functions malian Janus kinase family exist: Jak1, Jak2, Jak3, and
in host defense. Investigation of how these extracellular Tyk2 (Figure 1). Large kinases of approximately one
messengers regulate cell function led to the elucidation thousand amino acids, the Jaks have clear nonredun-
of the roles of Janus kinases and the Stat (signal trans- dant in vivo functions, identified by the analysis of mice,
ducer and activation of transcription) family of transcrip- and in the case of Jak3, humans deficient in this kinase.
tion factors, establishing this as a remarkably simple In Vivo Function
pathway for membrane to nucleus signaling. In this re- Jak3
view the most recent advances in this field will be em- Jak3 selectively associates with c and not other cyto-
phasized, but even this is not a simple task, as within kine receptors. Accordingly, mutation of c or Jak3 re-
the last 2 years alone more than 1500 articles have been sults in severe combined immunodeficiency, character-
published on Jaks and Stats. Our purpose then is not ized by the lack of T and NK cells, but not B cells, thus
to provide a comprehensive, historical review but rather designated TB SCID (reviewed in Notarangelo et al.,
to discuss the major lessons learned, examine the re- [2001]). Gene targeting of Jak3 in mice also results in
maining controversies, and comment on new develop- SCID, with reduced numbers of lymphoid cells and a
ments. References from the last century (including our near absence of thymic progenitor cells (Baird et al.,
own) will not be cited; interested readers are directed 2000). This is likely attributable to the failure of IL-7
to the following reviews: Darnell et al. (1994); Ihle (1995); signaling, whereas the absence of NK cell development
and Leonard and O’Shea (1998). has been attributed to the impairment in IL-15 signaling.
The lymphoid cells produced have a high apoptotic in-
New Players on the Field—Recently Identified dex, and accordingly Jak3 has been found to be a key
Cytokines and Receptors regulator of Bcl-2 and Bax (Wen et al., 2001).
New cytokines and receptors are continuing to be identi- A second important form of apoptosis in lymphocytes
fied, and it is likely that there are still a number yet to is activation-induced cell death (AICD). Regulated by
be characterized. Interleukin (IL)-21 is a new member of cytokines, this form of apoptosis is not Bcl-2 dependent
the cytokine subfamily that binds the common  chain, but is, rather, controlled by engagement of Fas. Notably,
c, and is produced by activated T cells (Asao et al., Jak3/ mice have expansion of CD4 T cells, which
2001; Parrish-Novak et al., 2000). Thymic stromal lym- express activation markers but have a restricted TCR
phopoietin is another cytokine that binds the IL-7 repertoire (Gozalo-Sanmillan et al., 2001). This is consis-
chain, but apparently does not require c for signaling tent with the importance of IL-2 in regulating peripheral
(Pandey et al., 2000; Park et al., 2000b). IL-12 is the tolerance and lymphoid homeostasis. Thus, Jak3-defi-
product of two genes, which encode subunits desig- cient lymphocytes exhibit the paradox of having both
too much and too little apoptosis. Recently, a Jak3 SCID
family was identified with apparently leaky mutations3 Correspondence: osheaj@arb.niams.nih.gov
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domain, which has essential regulatory functions (Chen
et al., 2000a; Saharinen et al., 2000; Yeh et al., 2000). A
number of patients with Jak3-SCID have mutations in
the pseudokinase domain. Conversely, a mutation of in
the JH2 domain of the Drosophila Jak, Hopscotch, is
transforming (Zeidler et al., 2000); however, without ac-Figure 1. Schematic of Janus Kinase Structure
tual structural data, one can only speculate as to howJanus kinases comprise FERM, SH2, pseudokinase, and kinase do-
these mutants might be exerting their effects.mains. The FERM domain mediates receptor interactions. Both the
FERM and pseudokinase domains regulate catalytic activity. The amino terminus of the Jaks is a relatively divergent
region of about 300 amino acids that has homology to
band four point one, ezrin, radixin, and moesin and is
referred to as the FERM domain. The Jak FERM domainthat allowed for T cell development. This was associated
mediates receptor association and regulates catalyticwith severe lymphoproliferative disease in one child,
activity (Hilkens et al., 2001; Zhou et al., 2001).presumably due to defective AICD (Frucht et al., 2001b).
For some receptors, including the IFN/R, EpoR,Jak1
PrlR, and oncostatin M (OSM)R, the Jak FERM domainIn contrast to Jak3, Jak1 is widely expressed and associ-
provides a chaperone function, influencing plasmaates with the IFN receptors and receptors that use gp130
membrane expression of the receptor (Huang et al.,and c. Jak1/ mice have grossly normal nonlymphoid
2001; Radtke et al., 2002). However, this may not beorganogenesis; however, Jak1/ mice die perinatally
requisite for all cytokine receptors. For instance, in theof an ill-characterized defect that may be neurologic.
absence of Jak3, c expression is evidently not impairedPresumably this is due to failure of signaling via cyto-
(Suzuki et al., 2000). Clearly, these are interesting find-kines that use gp130, which require Jak1 and promote
ings that warrant further study.neuronal survival. Like Jak3/ mice, Jak1/ mice have
Jak Associated ProteinsSCID, consistent with the idea that Jak1 binds to the
In addition to cytokine receptors, the SH3- and ITAM-ligand-specific receptor subunit of c-using cytokines.
containing molecule STAM1 also associates with Jak2Using cells from these mice, Jak1 also was found to be
and Jak3, is phosphorylated in response to cytokines,essential for signaling by IFN-/ and IFN-, in agree-
and augments signaling. However, Stam1/ mice havement with prior studies using a mutagenized cell line.
normal hematopoietic development and cytokine signal-Jak2
ing (Yamada et al., 2001). The relatively mild phenotypeLike Jak1, Jak2 is widely expressed and is involved in
associated with STAM1 deficiency may be related tosignaling by single chain hormone receptors, the com-
the existence of a second STAM protein, STAM2 (Endomon  chain family, and certain members of the class
et al., 2000) (Pandey et al., 2000). Additionally, the SH2II receptor cytokine family. Targeting of the murine Jak2
containing proteins SH2B and Aps bind and regulategene resulted in embryonic lethality at day 12.5 due to
the catalytic activity of some but not all Jaks (O’Brienfailure of erythropoiesis. Cells from these mice showed
et al., 2001). Thus, there appear to be a variety of proteinsthat Jak2 is essential for IL-3, granulocyte macrophage
that can regulate Jaks; but despite the overall structuralcolony stimulating factor (GM-CSF), IL-5, thrombopoie-
conservation of these kinases, they may be regulatedtin (Tpo), and IFN-, but not IL-6 and IFN/ signaling.
in subtly different manners.Transfer of Jak2/ fetal liver cells into irradiated Jak3/
In summary, it is clear that many questions remainrecipients resulted in normal thymic subsets, arguing
pertaining to the function and regulation of Janus ki-that Jak2 is not essential for T cell development.
nases. However, despite the gaps in our knowledge,A chromosomal translocation, [t(9;12)(p24;p13)], oc-
there is general agreement on the overall scheme ofcurs in a subset of leukemias, creating a fusion protein
cytokine signaling (Figure 2): ligand binding to cytokinecomprising the dimerization domain of the transcription
receptors results in the activation of prebound Jak ki-factor Tel and the kinase domain (or, in some cases,
nases, which auto- and transphosphorylate and phos-pseudokinase and kinase domains) of Jak2. Other trans-
phorylate the cytokine receptor on tyrosine residues.locations may result in Tel-Jak3 and Tel-Tyk2 fusion
The phosphorylated receptor is then recognized by pro-proteins.
teins with SH2 or PTB domains, which themselves be-Tyk2
come phosphorylated. One class of SH2 containing pro-First identified as an essential component in a screen
teins, the Stats, latent cytosolic transcription factors, isfor mutants in IFN- signaling, Tyk2/ mice have re-
particularly important in explaining cytokine action.markably subtle defects in IFN-/ signaling (Karaghio-
soff et al., 2000; Shimoda et al., 2000), perhaps one of
the biggest surprises in the field. Cells from these mice Stats
Stat1 and Stat2 were first identified as complexes thatare unresponsive to low doses of type I IFNs but have
relatively normal antiviral responses. IL-10 signaling is bound to response elements of interferon-inducible
genes. Now, a total of seven mammalian Stats haveessentially normal and IL-12 responses were reduced,
but not absent. Thus, unlike other Jaks, the in vivo nonre- been identified: Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b,
and Stat6 (Figure 3); again, large-scale sequencing ef-dundant functions of Tyk2 are modest.
Structure forts have failed to identify new members of this family
(Horvath, 2000; Ihle, 2001). It is now clear that this smallPresently, there is no detailed structural information on
this class of protein tyrosine kinases despite several family has critical functions in cytokine signal but is also
activated by other receptors, as well.unique features. One such feature is the pseudokinase
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Figure 2. Overview of Cytokine Signaling:
Positive and Negative Regulation
Cytokines bind to homodimeric or heterodi-
meric receptors, which bind Janus kinases
(Jaks). Jaks are activated by transphorylation
and they in turn phosphorylate cytokine re-
ceptors, allowing Stats to bind via SH2-phos-
photyrosine interactions. Stats themselves
are phosphorylated, permitting Stat dimeriza-
tion and translocation to the nucleus where
Stats bind DNA and regulate gene expres-
sion. This process is regulated at multiple
steps, some of which are summarized here:
tyrosine phosphatases such as SHP-1, CD45,
and PTP1b may regulate phosphorylation of
receptors and Jaks. Dimerized Stats can be
bound by PIAS members, which have been
found to be SUMO E3 ligases; the depicted
sumoylation of Stats, however, is a specula-
tive, albeit reasonable, possibility. Addition-
ally, cytokine stimulation induces the tran-
scription of a family of SH2 containing
proteins known as SOCS proteins. SOCS pro-
teins inhibit signaling by multiple means: (1)
binding and inhibiting Jaks, (2) binding cyto-
kine receptors and blocking Stats recruit-
ment, and (3) promoting ubiquitination and degradation of the Jak/receptor complex. Stats are dephosphorylated in the nucleus, but the
identity of the predominant nuclear Stat phosphatase (N-PTP) remains to be determined.
Stat Structure and Function and function, docking the protein to tyrosine phosphory-
lated receptor subunits. Additionally though, Stat2 andStats are proteins of 750 to 850 amino acids that contain
the following domains: amino terminal, coiled-coil, SH2, perhaps also Stat1 associate with the unactivated, non-
phosphorylated IFNAR prior to ligand binding. The re-linker, DNA binding, and transcriptional activation do-
mains. The crystal structure of two Stats, Stat1 and ceptor-bound Stats are then phosphorylated by Jaks
on a conserved tyrosine residue and the SH2 domainsStat3, bound to DNA has been solved (reviewed in (Hor-
vath, 2000), but the structures did not include the amino- mediate dimerization through reciprocal phosphotyro-
sine/SH2 interactions. The Stat SH2 domain may alsoand carboxy-terminal portions of the molecules. The
SH2 domain is an essential feature for Stat activation be important for association with the activating Jak.
The phosphorylated Stat dimer bound to DNA forms
a nutcracker-like structure with the SH2 domains form-
ing the hinge (Figure 3). The central portion (approxi-
mately aa 320-480) of the dimer forms a  barrel with
an immunoglobulin fold similar to NF-B and p53 and
is responsible for DNA binding, although the residues
that directly contact DNA are limited. Stat homodimers
bind a motif termed a GAS ( activated sequence) ele-
ment (TTN5-6AA). Unlike other cytokines, IFN-/ induces
the formation of a complex comprising Stat1, Stat2, and
IRF9 that binds the IFN-/-stimulated response ele-
ment (ISRE), AGTTN3TTTC.
While the importance of tyrosine phosphorylation and
dimerization of Stat proteins is clear, the mechanisms
that regulate nuclear import and export are an area of
intense investigation. Accumulation of Stat proteins in
the nucleus is clearly controlled by nuclear export via
Ran-dependent interaction with chromosome region
maintenance (CRM)1/exportin 1 (McBride et al., 2000).
A Leu-rich motif in the DNA binding domain of Stat1
(amino acids 400-409), conserved in other Stats, is criti-
Figure 3. Structure of Stats and the Phenotype of Stat Knockout cal for nuclear export. DNA binding of the phosphory-
Mice lated Stat dimer is proposed to mask the NES, whereas
Stat proteins have amino terminal, coiled-coil, DNA binding, linker, Stat dephosphorylation and dissociation from DNA per-
SH2, and transcriptional activation domains. The structure of a poly- mits recognition of this site, allowing nuclear export. It
peptide lacking the amino terminal domain and the TAD has been
should be noted that a different NES (amino acids 302-solved and is shown. Though the structure of the amino terminal
314) has also been mapped (Begitt et al., 2000).domain in isolation has been determined, the placement shown here
is conjectural. Inhibition of nuclear export alone is not sufficient to
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cause Stat nuclear accumulation; Stats are imported by formation due to severely impaired IFN responses, with
the induction of many well-known IFN-inducible genesthe nuclear import receptor, importin-5, and Ran. This
requires Stat dimerization, and tyrosine phosphorylation being abrogated. Although a number of cytokines and
growth factors can activate Stat1, to date there are noalone is not sufficient (McBride et al., 2002). Stat1 L407
appears to function as nuclear localization signal (NLS), major developmental deficits identified in these mice
attributable to non-IFN signaling. A missense mutationas mutations in this region of the protein interfere with
importin binding and nuclear import of phosphorylated of Stat1 has been identified in a patient suffering from
atypical mycobacterial infections, similar to individualsStat dimers (Melen et al., 2001; Meyer et al., 2002;
McBride et al. 2002). However, a bonafide, autono- with mutations of IFNR subunits. Interestingly though
this Stat1 mutation was not associated with susceptibil-mously functioning Stat NLS has yet to be defined. Addi-
tionally, nuclear trafficking of nonphosphorylated Stat ity to viral infections (Dupuis et al., 2001).
Naive CD4 T cells differentiate to T helper (Th)1 cells,monomers may occur by mechanisms distinct from
those that govern movement of dimers (Lillemeier et al., which produce IFN- and promote cell-mediated immu-
nity or Th2 cells, which drive allergic and anti-helminthic2001; Meyer et al., 2002).
Stat Transcriptional Regulation responses. The transcription factor T-bet has recently
been shown to be an important regulator of Th1 differen-The Stat C terminus contains an autonomously function-
ing transcriptional activation domain (TAD), and alterna- tiation. IFN- induces expression of T-bet in a feed-
forward mechanism, enhancing the ability of T cells totively spliced isoforms of Stat1, Stat3, and Stat4 lacking
this domain have attenuated transcriptional activity. produce IFN-; this regulation is Stat1 dependent (Ligh-
vani et al., 2001). However, T-bet expression is not com-Truncated Stat5 polypeptides lacking the TAD are
thought to be generated by proteolysis and are unstable pletely absent in Stat1-deficient mice, arguing for Stat1-
independent modes of T-bet regulation. Also, Stat1(Wang et al., 2000). While the mechanisms by which
these domains regulate transcription are incompletely activation is not sufficient to induce T-bet, since IFN-/
did not induce expression of this transcription factor.defined, serine phosphorylation within the TAD typically
promotes transcriptional activity and enhances the ex- IFNs are typically growth inhibitory and promote im-
mune recognition of target cells; thus, the demonstrationpression of selected genes (Decker and Kovarik, 2000;
Kovarik et al., 2001). This site, a putative mitogen-acti- that Stat1-deficient mice exhibit a higher incidence of
spontaneous and chemically induced tumors was veryvated protein kinase phosphorylation motif, encom-
passes serine 727 in Stat1 and Stat3. Stat4, Stat5a, and provocative (Shankaran et al., 2001). These findings
have generated renewed interest in the notion of im-Stat5b have similar residues in analogous positions, but
the identity of the kinase(s) responsible for these modifi- mune surveillance, with IFN- signaling serving as a
tumor suppressor system. The revised concept, how-cations remains a subject of some controversy. None-
theless, TAD phosphorylation could allow for regulation ever, is that tumors with impaired responsiveness to
IFN- have a selective advantage, allowing survival inand crosstalk by different receptors. The mechanism
underlying this regulation presumably involves the re- an immunocompetent host. There are likely multiple
mechanisms that underlie this process. Stat1 appearscruitment of other transcription factors and coactiva-
tors. Factors shown to bind the TAD include CBP/p300, to have important proapoptotic effects. Additionally, it
controls the expression of proteins involved in antigenc-Jun, MCM5, and BRCA1 (Horvath, 2000). CBP/p300
also binds other parts of the Stat molecule, and the presentation, thus affecting the immunogenicity of the
tumor.N-myc interacting protein (Nmi-1) facilitates this associ-
ation. Stat2, however, recruits a different histone acetyl- It should be noted that not all IFN- signaling is abro-
gated in Stat1/ cells. Using microarray technology andtransferase, GCN5 in complex with TAF130 (Paulson et
al., 2002). representational difference analysis, a surprisingly large
number of Stat1-independent genes were found to beStats also interact with a wide variety of other factors;
in addition to p48/IRF9, these factors include NF-B, induced by IFN-, consistent with the observations that
Stat1/ mice are less susceptible to infection than miceSMADs, Sp1, USF-1, c-Jun, PU.1, C/EBP, glucocorti-
coid receptor, NcoA-1, YY-1, TFII-1, and HMG-I(Y). lacking both IFN- and IFN/ receptors (Gil et al., 2001;
Ramana et al., 2001). Though IFNs typically inhibitSome of these interactions are mediated by the Stat
coiled-coil domain, but the Stat linker domain is also growth, in the absence of Stat1, they can be growth
promoting. Indeed, another class of genes can be identi-involved in transcriptional control. Additionally, the
amino terminus of the Stats forms a hook-like domain, fied–genes not ordinarily induced and even repressed
by IFN- when Stat1 is present, but that are induced inwhich may facilitate Stat interactions and cooperative
binding to tandem imperfect Stat binding sites. Thus, its absence; examples include c-jun, c-myc, and IFN-
(Nguyen et al., 2000). While the physiologic significancedespite what we have learned about Stats and transcrip-
tional regulation, it is very clear that we are only begin- of this regulation remains to be determined, the levels of
Stat1 are dynamic; one can therefore imagine complexning to understand these processes and the relevant
interactions. scenarios of gene regulation that may depend upon
the level of expression of Stat1. Of note, IFN-mediatedBiological Functions of Stats
Stat1 suppression of B cell growth is Stat1 independent, but
this appears to be due in part to the induction of theThe importance of Stat1 in IFN- and IFN/ signaling
was clearly established by the generation of Stat1-defi- proapoptotic molecule DAXX (Gongora et al., 2001).
While on the whole the deficits in Stat1/ mice arecient mice, confirming the initial findings in mutagenized
cell lines (Darnell et al., 1994). Stat1/ mice are highly indicative of IFN deficiency, IFN-independent roles of
Stat1 have been documented. For instance, natural killersusceptible to microbial and viral infections and tumor
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cell function is more severely impaired by Stat1 defi- sion by transactivating genes encoding proteins that
enhance cell survival (such as Bcl-2 and Bcl-XL). Stat3ciency than absence of both IFN- and IFN/ receptors
(Lee et al., 2000). and Stat5 are also frequently activated in cells that are
transformed with a variety of oncogenes (such as v-srcIn vivo, there is limited information supporting a criti-
cal role for Stat1 in growth factor signaling; however, and BCR-abl). Moreover, recent work has shown that
enforced expression of a constitutively active, disulfide-there is one example in which Stat1 can play an interest-
ing role in modulating signaling via a receptor tyrosine linked Stat3 homodimer is sufficient to transform immor-
talized fibroblasts, as detected by colony formation inkinase. Activating mutations of fibroblast growth factor
(FGF) receptors are associated with several forms of vitro and tumor formation in nude mice (Bromberg and
Darnell, 2000). Thus, Stat3 and Stat5 function in a man-human dwarfism and craniosynostosis syndromes. Ab-
sence of Stat1 counteracts these effects, suggesting ner that promotes growth and/or survival of transformed
cells, unlike Stat1, which inhibits these functions. Tu-that it may be an important aspect of FGF signaling that
leads to this pathology (Sahni et al., 2001). A consistent mors that express activated Stat3 and/or Stat5 often
additionally express activated Stat1. It has been specu-theme that emerges is that Stat1 serves as a negative
regulator of cell growth. As will be apparent shortly, lated that Stat1 and Stat3 maintain a critical biological
balance in normal growth-regulated cells and that per-this contrasts sharply with the function of other Stats,
especially Stat3 and Stat5. turbation of this balance may result in oncogenesis and/
or a transformed cellular phenotype.Stat2
The major function of Stat2 is its role in IFN-/ signal- Stat4
IL-12 promotes differentiation of naive CD4 T cells toing, where it complexes with Stat1 and IRF9 to bind
IRSEs. Accordingly, Stat2 knockout mice are fertile and Th1 cells, which produce IFN- and augment cell-medi-
ated immune responses. Th1 cells are critical in hostviable but are susceptible to viral infections, having im-
paired IFN-/ responsiveness (Park et al., 2000a). Stat1 defense against intracellular pathogens and tumors and
in the pathogenesis of autoimmune diseases such asupregulation in response of IFN- is also impaired in
Stat2-deficient cells. As a result, IFN- induction of GAS- rheumatoid arthritis, diabetes, and multiple sclerosis. IL-
12 activates Stat4 and the phenotype of Stat4 knockoutdependent genes, which are presumably not directly
dependent upon Stat2, is impaired nonetheless. How- mice is similar in most respects to mice lacking IL-12
or IL-12R subunits, having impaired Th1 differentiation,ever, the lack of IFN- responsiveness of GAS-driven
genes is not apparent in Stat2/ macrophages, which IFN- production, and cell-mediated immunity (Wurster
et al., 2000). Stat4 is also required for proper expressionexpress normal levels of Stat1.
Stat3 of IL-12R and IL-18R on Th1 cells (Lawless et al., 2000).
As might be predicted, Stat4-deficient mice are resis-Originally identified as an acute-phase response factor,
activated by IL-6, Stat3 is also activated by many other tant to autoimmune diseases characterized by a Th1
response, such as models of arthritis, diabetes, andcytokines. Targeted deletion of Stat3 is embryonically
lethal at day 7.5, necessitating the production of tissue- experimental allergic encephalomyelitis (EAE) (Chitnis
et al., 2001). Conversely, IL-12-, IL-12 receptor-, andspecific knockouts using Cre-lox technology (Akira,
2000). In general, tissue-specific targeting of Stat3 has Stat4-deficient mice have increased susceptibility to in-
fection with intracellular organisms. In acute sepsisnot been found to have major developmental conse-
quences; however, other abnormalities are apparent. though, Stat4 deficiency is associated with improved
survival, whereas Stat4/ mice had increased lethalityStat3-deficient T cells and hepatocytes have poor re-
sponses to IL-6 (Alonzi et al., 2001), whereas Stat3 defi- in a noninfectious sepsis model (Lentsch et al., 2001;
Matsukawa et al., 2001); apparently, Stat4 may haveciency in macrophages and neutrophils is associated
with exaggerated production of cytokines presumably either pro- or anti-inflammatory effects, depending upon
context.due to impaired IL-10 responsiveness. Deletion of Stat3
in mammary glands results in delayed programmed cell Stat4 is also activated by IL-23, and the exact func-
tions of IL-12 versus IL-23 will need to be sorted outdeath that occurs during cyclical mammary gland invo-
lution. Lack of Stat3 in keratinocytes permits normal (Oppmann et al., 2000). Additionally, in humans, but not
in mice, IFN-/ induces Stat4 phosphorylation. This isinitial development of skin and hair, but subsequent
hair cycles are disrupted. Skin wound healing, in vitro notable because IFN-/ can promote Th1 differentia-
tion in humans and not in mice. This has been explainedmigration of epidermal cells, and thymic architecture
are also disrupted (Sano et al., 2001). by the finding that Stat4 Stat2 is recruited to the human
type I IFN receptor via carboxy terminus of Stat2 (FarrarVery recently, selective targeting of the Stat3b isoform
was reported and these mice exhibit diminished recov- et al., 2000).
Stat4 is also inducible in dendritic cells and macro-ery from endotoxic shock and hyperresponsiveness of
some endotoxin-inducible genes in liver. This is the first phages; as in lymphocytes, Stat4 appears to be impor-
tant for production of IFN- in nonlymphoid cells. Thisin vivo evidence that Stat isoforms have essential in vivo
functions (Yoo et al., 2002). has been a controversial issue that now appears to have
a mechanistic basis and may be a means by which DCMany different tumor cell lines and fresh isolates de-
rived from a variety of different tumors, including breast, promote Th1 differentiation (Frucht et al., 2001a).
Stat6hematopoietic, head and neck, lung, kidney, prostate,
and ovarian cancers express activated forms of Stat3 Exposure of naive CD4 cells to IL-4 generates Th2 cells,
which are important in host defense against helminthesand Stat5 (Bowman et al., 2000; Levy and Gilliland,
2000). These Stats are often activated upon engagement and allergic responses. Activated by IL-4 and IL-13,
Stat6 is critical for Th2 differentiation. Accordingly,of growth factor receptors and facilitate cellular expan-
Cell
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Stat6/ mice have defective responses to these cyto-
kines (Wurster et al., 2000; Zhu et al., 2001). Stat6
regulates the expression of GATA-3 and c-maf, two tran-
scription factors in involved Th2 function. Th2 differenti-
ation is also associated with remodeling of chromatin
in the IL-4 locus and Stat6 is essential for this event
(Okamura and Rao, 2001). Additionally, Stat6-deficient
B cells are unable to undergo class switching and pro-
duce IgE. Via Stat6, IL-4 also antagonizes Th1 re-
sponses. In fact, residual Stat4-independent Th1 differ-
entiation becomes apparent in doubly deficient Stat4/
Stat6 knockout mice.
As expected, Stat6/ mice have impaired expulsion
of helminthic parasites, reduced pathology in models of
asthma, and exaggerated severity of Th1 diseases like Figure 4. Structure of SOCS and PIAS Family Members
EAE (Chitnis et al., 2001). Stat6/ mice have increased
SOCS proteins have a central SH2 domain and a C-terminal SOCS
lethality, inflammation, and cytokine production in a box; SOCS1 and SOCS3 also have a kinase-interacting region (KIR).
noninfectious model of endotoxemia, but reduced le- PIAS proteins contain a SAP (SAF-A/B, Acinus and PIAS) domain,
a ring-finger domain and C-terminal serine/threonine rich region.thality and enhanced clearance of bacteria in an infec-
tious model (Lentsch et al., 2001; Matsukawa et al.,
2001). Stat6 deficiency is associated with enhanced tu-
Negative Regulation Cytokine Signalingmor immunity (Terabe et al., 2000).
The mechanisms of negative regulation of signaling areStat5
the subject of several recent reviews (Krebs and Hilton,The products of the closely related (90% identical)
2001; Yasukawa et al., 2000) and will be briefly consid-and chromosomally linked Stat5a and Stat5b genes are
ered here. Several protein tyrosine phosphatases (PTP)activated by a wide range of cytokines. It was striking
including SHP-1, CD45, and PTP1b have been shownthat mice singly deficient in each of these genes had a
to be negative regulators of cytokine signaling (Irie-very specific and limited phenotype. Stat5a knockout
Sasaki et al., 2001; Myers et al., 2001). CD45 is a hemato-mice have loss of Prl-mediated mammary gland devel-
poietic-specific phosphatase, but cytokine receptors,opment, whereas Stat5b-deficient mice have sexually
Jaks, and Stats are widely expressed; what phospha-dimorphic growth retardation. In contrast, many
tases(s) perform CD45’s function in nonhematopoieticStat5a/b double knockout mice die within a few weeks
tissues? PTP1b binds Jak2 and Tyk2 via the phosphory-of birth, are infertile with defective corpus luteum devel-
lated activation loop and inhibits signaling, but Jak1 andopment, and have defective mammary gland develop-
Jak3 are apparently not regulated by this phosphatase.
ment. Both male and female Stat5a/b-deficient mice are
After translocation to the nucleus, Stats are dephos-
small with reduced size of fat pads and reduced levels
phorylated, but the identity of the nuclear Stat phospha-
of insulin-like growth factor-1 (IGF-1). Stat5a/b double
tase has not been established.
knockout mice also have hypocellular bone marrow, SOCS/Jab/SSI/CIS
lymphopenia, neutrophilia, and modest anemia and Initially identified as cytokine-inducible inhibitors of cy-
thrombocytopenia (Bunting et al., 2002; Snow et al., tokines, this family comprises at least eight members
2002). More impressive is the reduced ability of Stat5a/ with a central SH2 domain and a carboxy terminal
b-deficient hematopoietic progenitors to repopulate “SOCS box” (Figure 4), but only four members, CIS,
marrow, especially in competitive repopulation assays. SOCS1, SOCS2, and SOCS3, have been studied to any
Myeloid development is grossly normal in Stat5a/b extent.
knockout mice, but in vitro cytokine-dependent prolifer- The essential negative regulatory function of SOCS1 is
ation, survival, and migration of myeloid cells to sites evidenced by the fatal, immune-mediated inflammatory
of inflammation in vivo are impaired (Kieslinger et al., disease present in SOCS1/ mice. These mice are via-
2000). These mice have reduced numbers of B cell pre- ble and fertile but die at 3 weeks of age with a disorder
cursors and mature B cells and reduced responsiveness characterized by severe lymphopenia, activated T cells,
to IL-7, but immunoglobulins are not reduced (Sexl et macrophage infiltration, fatty degeneration, and necro-
al., 2000). NK cells are absent but thymic development sis of the liver. This disorder is present in mice in which
is intact; however, peripheral T cells from these mice the SOCS box is selectively deleted, illustrating its criti-
constitutively express activation markers and have im- cal function (Zhang et al., 2001). IFN- and TNF are
paired in vitro proliferation. Presumably this reflects in produced in high levels in these mice and the acute
vivo activation, a phenotype that is similar to IL-2- and pathologic changes are attenuated by the lack of IFN-,
IL-2 receptor-deficient mice and may be the conse- Stat1, Stat6, T cells, and NK T cells (Naka et al., 2001).
quence of defective AICD. Stat5a/b/ mice, like IL-2/ Over time however, mice lacking both SOCS-1 and IFN-
mice, develop autoimmunity, and this also contributes develop chronic multiorgan pathology, including poly-
to their pathology. cystic kidneys, pneumonia, skin ulcers, granulomas, and
Interestingly, Stat5 deficiency abrogates transforma- a slightly increased incidence of spontaneous and in-
tion by Tel-Jak but not v-Abl or BCR-abl-mediated trans- duced T cell leukemias (Metcalf et al., 2002).
SOCS2-deficient mice exhibit gigantism similar to GHformation (Schwaller et al., 2000; Sexl et al., 2000).
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Table 1. Phenotype of Nullizygous Mice
Gene Phenotype
Jak1 Viable but perinatal lethality due to neurologic deficits, SCID.
Jak2 Embryonically lethal due to failure in erythropoiesis.
Jak3 Viable and fertile, SCID.
Tyk2 Viable and fertile, defective IL-12 signaling especially in NK cells, increased susceptibility to selected viral infections.
Stat1 Viable and fertile, defective IFN/ and IFN- functions, increased tumorigenicity.
Stat2 Viable and fertile, defective IFN-/ functions, reduced Stat1 expression in some tissues.
Stat3 Embryonic lethal, conditional knockouts define tissue specific functions (see text).
Stat4 Viable and fertile, defective IL-12-driven Th1 differentiation, increased susceptibility to intracellular pathogens.
Stat5A Viable and fertile, defective in prolactin functions and mammary gland development.
Stat5B Viable and fertile, defective in sexually dimorphic growth.
Stat5 A/B Viable, female infertility, defective mammary gland development, reduced body mass in males and females, defective
T cell proliferation.
Stat6 Viable and fertile, defective IL-4-driven Th2 differentiation, increased susceptibility to helminthic infestation.
Stat4/6 Viable and fertile, defective Th-2 differentiation (Th1 skewed).
SOCS1 Viable but perinatal lethality severe IFN--dependent inflammatory disease.
SOCS2 Viable and fertile. Gigantism due to increased growth hormone and IGF-1.
SOCS3 Embryonically lethal due to placental defects and erythrocytosis.
CIS Viable and fertile — no phenotype reported.
and IGF-1 transgenic mice (Metcalf et al., 2000). In con- ever, it is now known that PIAS proteins interact with a
variety of different proteins and can serve as E3-liketrast, SOCS3 deficiency is embryonic lethal, but the ba-
sis of this lethality is somewhat controversial. One study ligases for sumoylation (Jackson, 2001). This begs the
obvious questions—are Stats sumoylated, and howreported that SOCS3/ embryos have marked erythro-
cytosis, consistent with the finding that transgenic ex- might this modification alter Stat function? An additional
interesting twist is that inhibition of Arg methylation bypression of SOCS3 resulted in inhibition of erythropoie-
sis. However, a more recent study indicated that SOCS3 methylthioadenosine of Stat1 promotes PIAS binding
(Mowen et al., 2001). Transformed cells can lack methyl-deficiency resulted in placental defects (Roberts et al.,
2001). thioadenosine phosphorylase and thereby accumulate
methyl thioadenosine; this might impair IFN responsesDespite their overall similarity in structure, SOCS fam-
ily members apparently have distinct mechanisms of and enhance tumorigenesis.
inhibition of signaling. First, SOCS1 and SOCS3 can bind
Jaks but the ability to inhibit their catalytic activity is Conclusions
In this review we have tried to highlight the state of thevariable. In the case of Jak2, Y1007 in the activation
loop binds the SOCS1 SH2 domain (Yasukawa et al., art of Jaks and Stats, a field of intense study. The vast
number of recent publications is indicative of just how2000). Additionally though, both SOCS1 and SOCS3
have a region immediately N-terminal to the SH2 domain quickly this field is moving—and it’s not just details. On
the contrary, it is absolutely clear that Jaks and Statstermed the kinase inhibitory region, which may function
as a pseudosubstrate and bind in the Jak catalytic are critical regulators of many key processes involving
cell fate and differentiation.pocket. In contrast, CIS binds to cytokine receptors and
blocks STAT recruitment to the receptor; neither CIS A particularly exciting area is the investigation of func-
tion of Jaks and Stats in model organisms such as Dicty-nor SOCS2 bind Jaks. Interestingly, SOCS3 binds both
the cytokine receptor and the Jak (Nicholson et al., ostelium and Drosophila (Williams, 2000; Zeidler et al.,
2000). Multiple Dictyostelium Stats play important roles2000); SOCS3 is recruited to the tyrosine-phosphory-
lated receptor, facilitating inhibition of the Jak. However, in the lifecycle of this organism, but no Jak or cytokine
receptor has been identified in this organism; in thisrecruitment of SOCS3 may not inhibit all signaling;
SOCS3 can also bind RasGAP and consequently en- case, it appears that entirely different types of receptors
are involved (Fukuzawa et al., 2001). A “complete Jak/hance Ras signaling (Cacalano et al., 2001). Promotion
of protein degradation is a fourth, but not mutually exclu- Stat” pathway is present in Drosophila (Zeidler et al.,
2000) and recently a cytokine receptor has also beensive, mechanism by which SOCS attenuate signaling.
The SOCS box binds the elongin B/C complex, which identified. Termed domeless or mom, it is similar to
LIFR and CNTFR (Brown et al., 2001) and its ligand is abinds an E3-like ubiquitin ligase, cullin-2, and regulates
proteosomal degradation. This mechanism of inhibition secreted molecule designated unpaired. This pathway
also has been shown to be critically involved in pro-serves to downregulate transformation by Tel-Jak2
(Frantsve et al., 2001; Kamizono et al., 2001). cesses such as embryonic segmentation, sex determi-
nation, larval hematopoiesis, eye, wing and leg develop-PIAS, Stat Methylation, and the SUMO
Connection ment, stem cell maintenance, and ovarian cell migration
(Jinks et al., 2000; Kiger et al., 2001; Sefton et al., 2000;Protein inhibitor of activated Stat (PIAS)1, identified in
a yeast two-hybrid screen (Figure 4), is one of several Silver and Montell, 2001; Tulina and Matunis, 2001;
Zeidler et al., 2000). This is surely an exciting area ofmembers of a family that now includes PIAS3 (KchAP),
PIASy, and PIASx (ARIP3) (Shuai, 2000). These proteins investigation.
While Jak- and Stat-deficient humans and mice dra-bind activated Stat dimers and block transcription. How-
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Baird, A.M., Lucas, J.A., and Berg, L.J. (2000). A profound deficiencymatically illustrate the essential in vivo functions of these
in thymic progenitor cells in mice lacking Jak3. J. Immunol. 165,molecules, an important question in the field is to what
3680–3688.extent, if any, Jaks and Stats are important for signaling
Begitt, A., Meyer, T., van Rossum, M., and Vinkemeier, U. (2000).for non-Type I/II cytokines. Virtually all classes of ligands
Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-
and receptors have been reported to activate Jaks and rich export signal in the coiled-coil domain. Proc. Natl. Acad. Sci.
Stats, but are they essential components for signaling? USA 97, 10418–10423.
This is still an open question; the data from Dictyostelium Blumberg, H., Conklin, D., Xu, W.F., Grossmann, A., Brender, T.,
would argue that Stats at least, have important functions Carollo, S., Eagan, M., Foster, D., Haldeman, B.A., Hammond, A.,
et al. (2001). Interleukin 20: discovery, receptor identification, andfor non-cytokine receptors, but is this also the case for
role in epidermal function. Cell 104, 9–19.Jaks? Another important issue is that many cytokines
Bowman, T., Garcia, R., Turkson, J., and Jove, R. (2000). STATs inactivate multiple Stats. Given the very different functions
oncogenesis. Oncogene 19, 2474–2488.of the Stats, it will be of interest to determine the signifi-
Bromberg, J., and Darnell, J.E., Jr. (2000). The role of STATs incance of these findings. Additionally, the finding of many
transcriptional control and their impact on cellular function. Onco-IFN-inducible genes in Stat1-deficient cells illustrates
gene 19, 2468–2473.that important Stat-independent signals exist. Do other
Brown, S., Hu, N., and Hombria, J.C. (2001). Identification of the firstStats provide compensatory signals, or is the control of
invertebrate interleukin JAK/STAT receptor, the Drosophila gene
these genes entirely unrelated to Stats? Clearly these domeless. Curr. Biol. 11, 1700–1705.
findings provide impetus to try to sort out the mecha-
Bunting, K.D., Bradley, H.L., Hawley, T.S., Moriggl, R., Sorrentino,
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A major developing area of unquestioned physiologic activity from adult bone marrow and fetal liver of mice lacking ex-
pression of STAT5. Blood 99, 479–487.relevance is that viruses possess a number of mecha-
nisms that circumvent IFN action and interdict Jak/Stat Cacalano, N.A., Sanden, D., and Johnston, J.A. (2001). Tyrosine-
phosphorylated SOCS-3 inhibits STAT activation but binds to p120signaling, with different viruses using distinct mech-
RasGAP and activates Ras. Nat. Cell Biol. 3, 460–465.anisms. Mechanisms identified thus far include desta-
Chen, M., Cheng, A., Candotti, F., Zhou, Y.J., Hymel, A., Fasth, A.,bilization of Jak and Stat proteins and perhaps other
Notarangelo, L.D., and O’Shea, J.J. (2000a). Complex effects oftranscription factors (Levy and Garcia-Sastre, 2001;
naturally occurring mutations in the JAK3 pseudokinase domain:Parisien et al., 2001). Conversely, IFNs circumvent virus- evidence for interactions between the kinase and pseudokinase
imposed cellular inhibitions; for instance, IFNs upregu- domains. Mol. Cell. Biol. 20, 947–956.
late nucleoporins to release vesicular stomatitis virus- Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M.H., Gurney, A.,
mediated mRNA nuclear export block (Enninga et al., Grewal, I.S., and de Sauvage, F.J. (2000b). Development of Th1-
2002). Furthermore, poliovirus promotes degradation of type immune responses requires the type I cytokine receptor TCCR.
Nature 407, 916–920.TATA binding protein (TBP); however, IFN-dependent
Chitnis, T., Najafian, N., Benou, C., Salama, A.D., Grusby, M.J., Say-transcription functions independently of TBP and thus
egh, M.H., and Khoury, S.J. (2001). Effect of targeted disruption ofcan evade the viral block (Paulson et al., 2002). This
STAT4 and STAT6 on the induction of experimental autoimmunework is just beginning to appear in literature, but the
encephalomyelitis. J. Clin. Invest. 108, 739–747.
interplay between viruses and elements in IFN signaling
Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT path-will, no doubt, continue to receive a lot of attention in
ways and transcriptional activation in response to IFNs and other
the future. This is also an area that might be capitalized extracellular signaling proteins. Science 264, 1415–1421.
upon for the development of novel therapies. Decker, T., and Kovarik, P. (2000). Serine phosphorylation of STATs.
Finally, immense progress continues to be made in Oncogene 19, 2628–2637.
identifying mechanisms involved in chromatin modifica- Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig,
tion and how these alterations promote or repress tran- S., Harris, J., Holland, S.M., Schreiber, R.D., and Casanova, J.L.
scription (Jenuwein and Allis, 2001). It is clear that cyto- (2001). Impairment of mycobacterial but not viral immunity by a
germline human STAT1 mutation. Science 293, 300–303.kine signaling leads to chromatin remodeling, but what
Endo, K., Takeshita, T., Kasai, H., Sasaki, Y., Tanaka, N., Asao, H.,are the precise steps that govern this process? This is
Kikuchi, K., Yamada, M., Chenb, M., O’Shea, J.J., et al. (2000).sure to be an exciting area of investigation.
STAM2, a new member of the STAM family, binding to the JanusThese concluding statements highlight just a few
kinases. FEBS Lett. 477, 55–61.
emerging areas of provocative work. It is clear that this
Enninga, J., Levy, D.E., Blobel, G., and Fontoura, B.M. (2002). Rolecontinues to be an exciting field; there are plenty of
of nucleoporin induction in releasing an mRNA nuclear export block.
excellent tools and no shortage of fascinating areas for Science 295, 1523–1525. Published online February 22, 2002.
study. Farrar, J.D., Smith, J.D., Murphy, T.L., Leung, S., Stark, G.R., and
Murphy, K.M. (2000). Selective loss of type I interferon-induced
STAT4 activation caused by a minisatellite insertion in mouse Stat2.References
Nat. Immunol. 1, 65–69.
Akira, S. (2000). Roles of STAT3 defined by tissue-specific gene Frantsve, J., Schwaller, J., Sternberg, D.W., Kutok, J., and Gilliland,
targeting. Oncogene 19, 2607–2611. D.G. (2001). Socs-1 inhibits TEL-JAK2-mediated transformation of
hematopoietic cells through inhibition of JAK2 kinase activity andAlonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., and Poli,
induction of proteasome- mediated degradation. Mol. Cell. Biol. 21,V. (2001). Essential role of STAT3 in the control of the acute-phase
3547–3557.response as revealed by inducible gene inactivation [correction of
activation] in the liver. Mol. Cell. Biol. 21, 1621–1632. Frucht, D.M., Fukao, T., Bogdan, C., Schindler, H., O’Shea, J.J., and
Koyasu, S. (2001a). IFN- production by antigen-presenting cells:Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster,
mechanisms emerge. Trends Immunol. 22, 556–560.D., and Sugamura, K. (2001). Cutting edge: the common -chain is
an indispensable subunit of the IL-21 receptor complex. J. Immunol. Frucht, D.M., Gadina, M., Jagadeesh, G.J., Aksentijevich, I., Takada,
K., Bleesing, J.J., Nelson, J., Muul, L.M., Perham, G., Morgan, G.,167, 1–5.
Review
S129
et al. (2001b). Unexpected and variable phenotypes in a family with components of IFN--inducing signaling pathways. J. Immunol. 165,
6803–6808.JAK3 deficiency. Genes Immunol. 2, 422–432.
Lee, C.K., Rao, D.T., Gertner, R., Gimeno, R., Frey, A.B., and Levy,Fukuzawa, M., Araki, T., Adrian, I., and Williams, J.G. (2001). Tyrosine
D.E. (2000). Distinct requirements for IFNs and STAT1 in NK cellphosphorylation-independent nuclear translocation of a Dictyostel-
function. J. Immunol. 165, 3571–3577.ium STAT in response to DIF signaling. Mol. Cell 7, 779–788.
Lentsch, A.B., Kato, A., Davis, B., Wang, W., Chao, C., and Edwards,Gil, M.P., Bohn, E., O’Guin, A.K., Ramana, C.V., Levine, B., Stark,
M.J. (2001). STAT4 and STAT6 regulate systemic inflammation andG.R., Virgin, H.W., and Schreiber, R.D. (2001). Biologic conse-
protect against lethal endotoxemia. J. Clin. Invest. 108, 1475–1482.quences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci.
USA 98, 6680–6685. Leonard, W.J., and O’Shea, J.J. (1998). Jaks and STATs: biological
implications. Annu. Rev. Immunol. 16, 293–322.Gongora, R., Stephan, R.P., Zhang, Z., and Cooper, M.D. (2001). An
essential role for Daxx in the inhibition of B lymphopoiesis by type Levy, D.E., and Gilliland, D.G. (2000). Divergent roles of STAT1 and
I interferons. Immunity 14, 727–737. STAT5 in malignancy as revealed by gene disruptions in mice. Onco-
gene 19, 2505–2510.Gozalo-Sanmillan, S., McNally, J.M., Lin, M.Y., Chambers, C.A., and
Berg, L.J. (2001). Cutting edge: two distinct mechanisms lead to Levy, D.E., and Garcia-Sastre, A. (2001). The virus battles: IFN induc-
impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient tion of the antiviral state and mechanisms of viral evasion. Cytokine
mice. J. Immunol. 166, 727–730. Growth Factor Rev. 12, 143–156.
Guo, Z., Zhou, D., and Schultz, P.G. (2000). Designing small-mole- Lighvani, A.A., Frucht, D.M., Jankovic, D., Yamane, H., Aliberti, J.,
cule switches for protein-protein interactions. Science 288, 2042– Hissong, B.D., Nguyen, B.V., Gadina, M., Sher, A., Paul, W.E., et al.
2045. (2001). T-bet is rapidly induced by interferon-gamma in lymphoid
and myeloid cells. Proc. Natl. Acad. Sci. USA 98, 15137–15142.Hilkens, C.M., Is’harc, H., Lillemeier, B.F., Strobl, B., Bates, P.A.,
Behrmann, I., and Kerr, I.M. (2001). A region encompassing the Lillemeier, B.F., Koster, M., and Kerr, I.M. (2001). STAT1 from the
FERM domain of Jak1 is necessary for binding to the cytokine recep- cell membrane to the DNA. EMBO J. 20, 2508–2517.
tor gp130. FEBS Lett. 505, 87–91. Matsukawa, A., Kaplan, M.H., Hogaboam, C.M., Lukacs, N.W., and
Kunkel, S.L. (2001). Pivotal role of signal transducer and activatorHorvath, C.M. (2000). STAT proteins and transcriptional responses
to extracellular signals. Trends Biochem. Sci. 25, 496–502. of transcription (Stat)4 and Stat6 in the innate immune response
during sepsis. J. Exp. Med. 193, 679–688.Huang, L.J., Constantinescu, S.N., and Lodish, H.F. (2001). The
McBride, K.M., McDonald, C., and Reich, N.C. (2000). Nuclear exportN-terminal domain of janus kinase 2 is required for Golgi processing
signal located within theDNA-binding domain of the STAT1trans-and cell surface expression of erythropoietin receptor. Mol. Cell 8,
cription factor. EMBO J. 19, 6196–6206.1327–1338.
McBride, K.M., and Banninger, G. McDonald, C and Reich, N.C.Ihle, J.N. (1995). Cytokine receptor signalling. Nature 377, 591–594.
(2002). Regulated nuclear import of the Stat1 transcription factorIhle, J.N. (2001). The Stat family in cytokine signaling. Curr. Opin.
by direct binding of importin-. EMBO J., in press.Cell Biol. 13, 211–217.
Melen, K., Kinnunen, L., and Julkunen, I. (2001). Arginine/lysine-richIrie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M.,
structural element is involved in interferon- induced nuclear importWelstead, G., Griffiths, E., Krawczyk, C., Richardson, C.D., Aitken,
of STATs. J. Biol. Chem. 276, 16447–16455.K., et al. (2001). CD45 is a JAK phosphatase and negatively regulates
Metcalf, D., Greenhalgh, C.J., Viney, E., Willson, T.A., Starr, R., Ni-cytokine receptor signalling. Nature 409, 349–354.
cola, N.A., Hilton, D.J., and Alexander, W.S. (2000). Gigantism in miceJackson, P.K. (2001). A new RING for SUMO: wrestling transcrip-
lacking suppressor of cytokine signalling-2. Nature 405, 1069–1073.tional responses into nuclear bodies with PIAS family E3 SUMO
Metcalf, D., Mifsud, S., Di Rago, L., Nicola, N.A., Hilton, D.J., andligases. Genes Dev. 15, 3053–3058.
Alexander, W.S. (2002). Polycystic kidneys and chronic inflammatoryJenuwein, T., and Allis, C.D. (2001). Translating the histone code.
lesions are the delayed consequences of loss of the suppressorScience 293, 1074–1080.
of cytokine signaling-1 (SOCS-1). Proc. Natl. Acad. Sci. USA 99,
Jinks, T.M., Polydorides, A.D., Calhoun, G., and Schedl, P. (2000). 943–948. Published online January 22, 2002.
The JAK/STAT signaling pathway is required for the initial choice
Meyer, T., Begitt, A., Lodige, I., van Rossum, M., and Vinkemeier,
of sexual identity in Drosophila melanogaster. Mol. Cell 5, 581–587.
U. (2002). Constitutive and IFN--induced nuclear import of STAT1
Kamizono, S., Hanada, T., Yasukawa, H., Minoguchi, S., Kato, R., proceed through independent pathways. EMBO J. 21, 344–354.
Minoguchi, M., Hattori, K., Hatakeyama, S., Yada, M., Morita, S., et al.
Mowen, K.A., Tang, J., Zhu, W., Schurter, B.T., Shuai, K., Herschman,
(2001). The SOCS box of SOCS-1 accelerates ubiquitin-dependent
H.R., and David, M. (2001). Arginine methylation of STAT1 modulates
proteolysis of TEL-JAK2. J. Biol. Chem. 276, 12530–12538.
IFN/-induced transcription. Cell 104, 731–741.
Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, Myers, M.P., Andersen, J.N., Cheng, A., Tremblay, M.L., Horvath,
H., Pircher, H., McCoy, B., Bogdan, C., Decker, T., Brem, G., et al. C.M., Parisien, J.P., Salmeen, A., Barford, D., and Tonks, N.K. (2001).
(2000). Partial impairment of cytokine responses in Tyk2-deficient TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B.
mice. Immunity 13, 549–560. J. Biol. Chem. 276, 47771–47774.
Kieslinger, M., Woldman, I., Moriggl, R., Hofmann, J., Marine, J.C., Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita,
Ihle, J.N., Beug, H., and Decker, T. (2000). Antiapoptotic activity Y., Nakagawa, R., Narazaki, M., Adachi, K., Yoshimoto, T., et al.
of Stat5 required during terminal stages of myeloid differentiation. (2001). SOCS-1/SSI-1-deficient NKT cells participate in severe hepa-
Genes Dev. 14, 232–244. titis through dysregulated cross-talk inhibition of IFN- and IL-4
Kiger, A.A., Jones, D.L., Schulz, C., Rogers, M.B., and Fuller, M.T. signaling in vivo. Immunity 14, 535–545.
(2001). Stem cell self-renewal specified by JAK-STAT activation in Nguyen, K.B., Cousens, L.P., Doughty, L.A., Pien, G.C., Durbin, J.E.,
response to a support cell cue. Science 294, 2542–2545. and Biron, C.A. (2000). Interferon /-mediated inhibition and pro-
Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., motion of interferon : STAT1 resolves a paradox. Nat. Immunol. 1,
Zotter, A., Levy, D.E., Muller, M., and Decker, T. (2001). Specificity 70–76.
of signaling by STAT1 depends on SH2 and C-terminal domains Nicholson, S.E., De Souza, D., Fabri, L.J., Corbin, J., Willson, T.A.,
that regulate Ser727 phosphorylation, differentially affecting specific Zhang, J.G., Silva, A., Asimakis, M., Farley, A., Nash, A.D., et al.
target gene expression. EMBO J. 20, 91–100. (2000). Suppressor of cytokine signaling-3 preferentially binds to
Krebs, D.L., and Hilton, D.J. (2001). SOCS proteins: negative regula- the SHP-2- binding site on the shared cytokine receptor subunit
tors of cytokine signaling. Stem Cells 19, 378–387. gp130. Proc. Natl. Acad. Sci. USA 97, 6493–6498.
Notarangelo, L.D., Mella, P., Jones, A., de Saint Basile, G., Savoldi,Lawless, V.A., Zhang, S., Ozes, O.N., Bruns, H.A., Oldham, I., Hoey,
T., Grusby, M.J., and Kaplan, M.H. (2000). Stat4 regulates multiple G., Cranston, T., Vihinen, M., and Schumacher, R.F. (2001). Muta-
Cell
S130
tions in severe combined immune deficiency (SCID) due to JAK3 abl- and bcr/abl-induced transformation are independent of stat5.
Blood 96, 2277–2283.deficiency. Hum. Mutat. 18, 255–263.
Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E.,O’Brien, K.B., O’Shea, J.J., and Carter-Su, C. (2001). SH2-B family
Old, L.J., and Schreiber, R.D. (2001). IFNgamma and lymphocytesmembers differentially regulate JAK family tyrosine kinases. J. Biol.
prevent primary tumour development and shape tumour immunoge-Chem. 277, 8673–8681. Published online March 8, 2002.
nicity. Nature 410, 1107–1111.Okamura, H., and Rao, A. (2001). Transcriptional regulation in lym-
Shimoda, K., Kato, K., Aoki, K., Matsuda, T., Miyamoto, A., Shiba-phocytes. Curr. Opin. Cell Biol. 13, 239–243.
mori, M., Yamashita, M., Numata, A., Takase, K., Kobayashi, S., etOppmann, B., Lesley, R., Blom, B., Timans, J.C., Xu, Y., Hunte, B.,
al. (2000). Tyk2 plays a restricted role in IFN  signaling, although itVega, F., Yu, N., Wang, J., Singh, K., et al. (2000). Novel p19 protein
is required for IL-12-mediated T cell function. Immunity 13, 561–571.engages IL-12p40 to form a cytokine, IL-23, with biological activities
Shuai, K. (2000). Modulation of STAT signaling by STAT-interactingsimilar as well as distinct from IL-12. Immunity 13, 715–725.
proteins. Oncogene 19, 2638–2644.Pandey, A., Fernandez, M.M., Steen, H., Blagoev, B., Nielsen, M.M.,
Silver, D.L., and Montell, D.J. (2001). Paracrine signaling through theRoche, S., Mann, M., and Lodish, H.F. (2000). Identification of a
JAK/STAT pathway activates invasive behavior of ovarian epithelialnovel immunoreceptor tyrosine-based activation motif-containing
cells in Drosophila. Cell 107, 831–841.molecule, STAM2, by mass spectrometry and its involvement in
growth factor and cytokine receptor signaling pathways. J. Biol. Snow, J.W., Abraham, N., Ma, M.C., Abbey, N.W., Herndier, B., and
Chem. 275, 38633–38639. Goldsmith, M.A. (2002). STAT5 promotes multilineage hematolym-
phoid development in vivo through effects on early hematopoieticParisien, J.P., Lau, J.F., Rodriguez, J.J., Sullivan, B.M., Moscona,
progenitor cells. Blood 99, 95–101.A., Parks, G.D., Lamb, R.A., and Horvath, C.M. (2001). The V protein
of human parainfluenza virus 2 antagonizes type I interferon re- Suzuki, K., Nakajima, H., Saito, Y., Saito, T., Leonard, W.J., and
sponses by destabilizing signal transducer and activator of tran- Iwamoto, I. (2000). Janus kinase 3 (Jak3) is essential for common
scription 2. Virology 283, 230–239. cytokine receptor  chain ((c))-dependent signaling: comparative
analysis of (c), Jak3, and (c) and Jak3 double-deficient mice. Int.Park, C., Li, S., Cha, E., and Schindler, C. (2000a). Immune response
Immunol. 12, 123–132.in Stat2 knockout mice. Immunity 13, 795–804.
Takahashi, I., Kosaka, H., Oritani, K., Heath, W.R., Ishikawa, J., Oka-Park, L.S., Martin, U., Garka, K., Gliniak, B., Di Santo, J.P., Muller,
jima, Y., Ogawa, M., Kawamoto, S., Yamada, M., Azukizawa, H., etW., Largaespada, D.A., Copeland, N.G., Jenkins, N.A., Farr, A.G., et
al. (2001). A new IFN-like cytokine, limitin, modulates the immuneal. (2000b). Cloning of the murine thymic stromal lymphopoietin
response without influencing thymocyte development. J. Immunol.(TSLP) receptor: formation of a functional heteromeric complex re-
167, 3156–3163.quires interleukin 7 receptor. J. Exp. Med. 192, 659–670.
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C.,Parrish-Novak, J., Dillon, S.R., Nelson, A., Hammond, A., Sprecher,
Donaldson, D.D., Carbone, D.P., Paul, W.E., and Berzofsky, J.A.C., Gross, J.A., Johnston, J., Madden, K., Xu, W., West, J., et al.
(2000). NKT cell-mediated repression of tumor immunosurveillance(2000). Interleukin 21 and its receptor are involved in NK cell expan-
by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1, 515–520.sion and regulation of lymphocyte function. Nature 408, 57–63.
Tulina, N., and Matunis, E. (2001). Control of stem cell self-renewal inPaulson, M., Press, C., Smith, E., Tanese, N., and Levy, D.E. (2002).
Drosophila spermatogenesis by JAK-STAT signaling. Science 294,IFN-stimulated transcription through a TBP-free acetyltransferase
2546–2549.complex escapes viral shutoff. Nat. Cell Biol. 21, 21.
Wang, D., Moriggl, R., Stravopodis, D., Carpino, N., Marine, J.C.,Radtke, S., Hermanns, H.M., Haan, C., Schmitz-Van De Leur, H.,
Teglund, S., Feng, J., and Ihle, J.N. (2000). A small amphipathicGascan, H., Heinrich, P.C., and Behrmann, I. (2002). Novel role for
alpha-helical region is required for transcriptional activities and pro-Janus kinase 1 in the regulation of oncostatin M receptor surface
teasome-dependent turnover of the tyrosine-phosphorylated Stat5.expression. J. Biol. Chem., in press. Published online January 10,
EMBO J. 19, 392–399.2002.
Wen, R., Wang, D., McKay, C., Bunting, K.D., Marine, J.C., Vanin,Ramana, C.V., Gil, M.P., Han, Y., Ransohoff, R.M., Schreiber, R.D.,
E.F., Zambetti, G.P., Korsmeyer, S.J., Ihle, J.N., and Cleveland, J.L.and Stark, G.R. (2001). Stat1-independent regulation of gene expres-
(2001). Jak3 selectively regulates Bax and Bcl-2 expression to pro-sion in response to IFN-. Proc. Natl. Acad. Sci. USA 98, 6674–6679.
mote T-cell development. Mol. Cell. Biol. 21, 678–689.Roberts, A.W., Robb, L., Rakar, S., Hartley, L., Cluse, L., Nicola,
Williams, J.G. (2000). STAT signalling in cell proliferation and inN.A., Metcalf, D., Hilton, D.J., and Alexander, W.S. (2001). Placental
development. Curr. Opin. Genet. Dev. 10, 503–507.defects and embryonic lethality in mice lacking suppressor of cyto-
kine signaling 3. Proc. Natl. Acad. Sci. USA 98, 9324–9329. Wurster, A.L., Tanaka, T., and Grusby, M.J. (2000). The biology of
Stat4 and Stat6. Oncogene 19, 2577–2584.Saharinen, P., Takaluoma, K., and Silvennoinen, O. (2000). Regula-
tion of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Xie, M.H., Aggarwal, S., Ho, W.H., Foster, J., Zhang, Z., Stinson, J.,
Cell. Biol. 20, 3387–3395. Wood, W.I., Goddard, A.D., and Gurney, A.L. (2000). Interleukin (IL)-
22, a novel human cytokine that signals through the interferon recep-Sahni, M., Raz, R., Coffin, J.D., Levy, D., and Basilico, C. (2001).
tor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275, 31335–STAT1 mediates the increased apoptosis and reduced chondrocyte
31339.proliferation in mice overexpressing FGF2. Development 128, 2119–
2129. Yamada, M., Takeshita, T., Miura, S., Murata, K., Kimura, Y., Ishii,
N., Nose, M., Sakagami, H., Kondo, H., Tashiro, F., et al. (2001). LossSano, S., Takahama, Y., Sugawara, T., Kosaka, H., Itami, S., Yoshi-
of hippocampal CA3 pyramidal neurons in mice lacking STAM1. Mol.kawa, K., Miyazaki, J., van Ewijk, W., and Takeda, J. (2001). Stat3
Cell. Biol. 21, 3807–3819.in thymic epithelial cells is essential for postnatal maintenance of
thymic architecture and thymocyte survival. Immunity 15, 261–273. Yasukawa, H., Sasaki, A., and Yoshimura, A. (2000). Negative regula-
tion of cytokine signaling pathways. Annu. Rev. Immunol. 18,Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J.C., Williams,
143–164.I.R., Lee, C.K., Gerthner, R., Kitamura, T., Frantsve, J., et al. (2000).
Stat5 is essential for the myelo- and lymphoproliferative disease Yeh, T.C., Dondi, E., Uze, G., and Pellegrini, S. (2000). A dual role
induced by TEL/JAK2. Mol. Cell 6, 693–704. for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-
 signaling. Proc. Natl. Acad. Sci. USA 97, 8991–8996.Sefton, L., Timmer, J.R., Zhang, Y., Beranger, F., and Cline, T.W.
(2000). An extracellular activator of the Drosophila JAK/STAT path- Yoo, J.-Y., Huso, D.L., Nathans, D., and Desiderio, S. (2002). Specific
way is a sex-determination signal element. Nature 405, 970–973. ablation of Stat3 distorts the pattern of Stat3-responsive gene ex-
pression and impairs recovery from endotoxic shock. Cell 108,Sexl, V., Piekorz, R., Moriggl, R., Rohrer, J., Brown, M.P., Bunting,
331–344.K.D., Rothammer, K., Roussel, M.F., and Ihle, J.N. (2000). Stat5a/b
contribute to interleukin 7-induced B-cell precursor expansion, but Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu,
Review
S131
S., Xia, M., Wakeham, A.C., Nishina, H., Potter, J., et al. (2001).
WSX-1 is required for the initiation of Th1 responses and resistance
to L. major infection. Immunity 15, 569–578.
Zeidler, M.P., Bach, E.A., and Perrimon, N. (2000). The roles of the
Drosophila JAK/STAT pathway. Oncogene 19, 2598–2606.
Zhang, J.G., Metcalf, D., Rakar, S., Asimakis, M., Greenhalgh, C.J.,
Willson, T.A., Starr, R., Nicholson, S.E., Carter, W., Alexander, W.S.,
et al. (2001). The SOCS box of suppressor of cytokine signaling-1
is important for inhibition of cytokine action in vivo. Proc. Natl. Acad.
Sci. USA 98, 13261–13265.
Zhou, Y.J., Chen, M., Cusack, N.A., Kimmel, L.H., Magnuson, K.S.,
Boyd, J.G., Lin, W., Roberts, J.L., Lengi, A., Buckley, R.H., et al.
(2001). Unexpected effects of FERM domain mutations on catalytic
activity of Jak3: structural implication for Janus kinases. Mol. Cell
8, 959–969.
Zhu, J., Guo, L., Watson, C.J., Hu-Li, J., and Paul, W.E. (2001). Stat6
is necessary and sufficient for IL-4’s role in Th2 differentiation and
cell expansion. J. Immunol. 166, 7276–7281.
